Cardioblate
Device Ablation
PDI 00885074266022
General payments
$75,820
Research payments
$1,087,806
Through program year 2025, $75,820 in general payments and $1,087,806 in research payments were reported against Cardioblate (Ablation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,610 | 51 |
| 2025 | Research | $154,467 | 72 |
| 2024 | General | $4,725 | 52 |
| 2024 | Research | $177,958 | 68 |
| 2023 | General | $18,340 | 142 |
| 2023 | Research | $257,846 | 98 |
| 2022 | General | $17,266 | 122 |
| 2022 | Research | $271,187 | 119 |
| 2021 | General | $32,880 | 169 |
| 2021 | Research | $226,348 | 70 |
Breakdown
The top 5 of 29 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
536 general · 427 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.